Classification of thyroid malignancies

Thyroid Cancer (Second Edition): A Comprehensive Guide to Clinical Management

Volumn , Issue , 2006, Pages 85-86

  Oertel, Yolanda C ^a,b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052997351     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59259-995-0_8     Document Type: Chapter

References (12)

1. Hedinger C, Williams ED, Sobin LH. Histological typing of thyroid tumours. World Health Organization International Histological Classification of Tumours, 2nd ed. Berlin: Springer-Verlag, 1988.
2. Rosai J, Carcangiu ML, DeLellis RA. Tumors of the thyroid gland. In Rosai J, Sobin H, editors. Atlas of Tumor Pathology, 3rd Series, Fasc 5. Washington, DC: A. F. I. P, 1992.
3. Hay ID. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1990; 19:545-576.
4. Pasieka L, Zedenius J, Auer G, et al. Addition of nuclear DNA content to the AMES risk-group classification for papillary thyroid cancer. Surgery 1992; 112:1154-1160.
5. Nishida T, Nakao K, Hamaji M, Nakahara M, Tsujimoto M. Overexpression of p53 protein and DNA content are important biologic prognostic factors for thyroid cancer. 1996; 119:568-575.
6. Sciacchitano S, Paliotta DS, Nardi F, Sacchi A, Andreoli M, Pontecorvi A. PCR amplification and analysis of RAS oncogenes from thyroid cytologic smears. Diagn Mol Pathol 1994; 3:114-121.
7. Hara H, Fulton N, Yashiro T, Ito K, DeGroot LJ, Kaplan EL. N-Ras mutation: an independent prognostic factor for aggressiveness of papillary thyroid carcinoma. Surgery 1994; 116:1010-1016.
8. Fagin JA, Matsuo K, Karmaker A, Chen DL, Tang S-H, Koeffler HP. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest 1993; 91:179-184.
9. Donghi R, Longoni A, Pilotti S, Michieli P, Delia Porta G, Pierotti MA. Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J Clin Invest 1993; 91:1753-1760.
10. Soares P, Cameselle-Teijeiro J, Sobrinho-Simoes M. Immuno-histochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid. Histopathology 1994; 24:205-210.
11. Pilotti S, Collini P, Del Bo R, Cattoretti G, Pierotti MA, Rilke F. A novel panel of antibodies that segregates immunocytochemically poorly differentiated carcinoma from undifferentiated carcinoma of the thyroid gland. Am J Surg Pathol 1994; 18:1054-1064.
12. Mazzanti C, Zeiger MA, Costourous N, Umbricht C, Westra WH, Smith D, et al. Using gene expression profiling to differentiate benign versus malignant thyroid tumors. Cancer Res 2004; 64:2898-2903.